GlobalData03.03.20
An increasing number of private and publicly owned dialysis centers contribute to the expansion of the renal dialysis machines market. This market is expected to reach $2.5 billion by 2028, growing at a compound annual growth rate (CAGR) of 3.2 percent, according to data and analytics company GlobalData.
Tina Deng, a medical devices analyst at GlobalData, said: “Data from Japan and U.S. renal registries showed a positive correlation between the number of dialysis patients and dialysis centers. The more dialysis centers were opened, the more patients were treated, and the more equipment is consumed. By combining the manufacture of machines with the running of clinics, the dialysis giant Fresenius has come to dominate both markets with a one-stop shopping model. Although a clinic run by Fresenius does not necessarily purchase dialysis products manufactured only by Fresenius, it will choose its own company when deciding among homogeneous products with the same cost. In addition, the company can pursue a consolidation strategy that allows it to negotiate a better deal and spread fixed costs over a great number of centers.”
Renal dialysis machines are intended to provide an artificial replacement for lost kidney function due to renal failure. Haemodialysis is the most common method used worldwide, while peritoneal dialysis has consistently gained acceptance. Dialyzers are artificial filters containing fine fibers. The fibers are hollow with microscopic pores in the wall, also known as semi-permeable dialysis membrane. To remove toxins during hemodialysis, a special dialysis-fluid flows through the filter, and bathes the fibers from the outside, while the blood flows through the hollow fiber. Due to the semi-permeable dialysis membrane, toxins, urea and other small particles can pass through the membrane.
The transfer of metabolic toxins through the membrane into the dialysis fluid is based on natural processes. This process is known as diffusion. In hemodialysis an artificial membrane (dialyzer) is used, In contrast, in peritoneal dialysis (the peritoneum which lines the abdomen walls) is used as a natural semi-permeable dialysis membrane.
Deng continued: “One key trend for haemodialysis machines is to give physicians treatment flexibility to meet the needs of individual patients. In addition to basic haemodialysis functions, touchscreen interfaces have been implemented for all new haemodialysis machines. Mirroring these trends, new peritoneal dialysis machines feature improved user interfaces and expanded therapy options as well. The growing demand for home-based care, increasing awareness of peritoneal dialysis, the rising cost of haemodialysis at dialysis centres, and the development of protocols are expected to drive the peritoneal dialysis market to new heights.”
Tina Deng, a medical devices analyst at GlobalData, said: “Data from Japan and U.S. renal registries showed a positive correlation between the number of dialysis patients and dialysis centers. The more dialysis centers were opened, the more patients were treated, and the more equipment is consumed. By combining the manufacture of machines with the running of clinics, the dialysis giant Fresenius has come to dominate both markets with a one-stop shopping model. Although a clinic run by Fresenius does not necessarily purchase dialysis products manufactured only by Fresenius, it will choose its own company when deciding among homogeneous products with the same cost. In addition, the company can pursue a consolidation strategy that allows it to negotiate a better deal and spread fixed costs over a great number of centers.”
Renal dialysis machines are intended to provide an artificial replacement for lost kidney function due to renal failure. Haemodialysis is the most common method used worldwide, while peritoneal dialysis has consistently gained acceptance. Dialyzers are artificial filters containing fine fibers. The fibers are hollow with microscopic pores in the wall, also known as semi-permeable dialysis membrane. To remove toxins during hemodialysis, a special dialysis-fluid flows through the filter, and bathes the fibers from the outside, while the blood flows through the hollow fiber. Due to the semi-permeable dialysis membrane, toxins, urea and other small particles can pass through the membrane.
The transfer of metabolic toxins through the membrane into the dialysis fluid is based on natural processes. This process is known as diffusion. In hemodialysis an artificial membrane (dialyzer) is used, In contrast, in peritoneal dialysis (the peritoneum which lines the abdomen walls) is used as a natural semi-permeable dialysis membrane.
Deng continued: “One key trend for haemodialysis machines is to give physicians treatment flexibility to meet the needs of individual patients. In addition to basic haemodialysis functions, touchscreen interfaces have been implemented for all new haemodialysis machines. Mirroring these trends, new peritoneal dialysis machines feature improved user interfaces and expanded therapy options as well. The growing demand for home-based care, increasing awareness of peritoneal dialysis, the rising cost of haemodialysis at dialysis centres, and the development of protocols are expected to drive the peritoneal dialysis market to new heights.”